Frontiers | Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram
IJMS | Free Full-Text | Immunomodulatory Role of Interferons in Viral and Bacterial Infections
Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
Human IFN-κ Inhibited Respiratory RNA Virus Replication Dependent on Cell-to-Cell Interaction in the Early Phase | Infectious Diseases & Immunity
Emerging concepts of type I interferons in SLE pathogenesis and therapy | Nature Reviews Rheumatology
Single-cell analysis of signalling and transcriptional responses to type I interferons | bioRxiv
How cancer cells make and respond to interferon-I: Trends in Cancer
Recombinant Mouse IFN-beta Protein 8234-MB-010: R&D Systems
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis | Science Signaling
IJMS | Free Full-Text | Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID
Interferon Kappa Is Up-Regulated in Psoriasis and It Up-Regulates Psor | CCID
Interferons | Bio-Techne
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology
Decoding type I and III interferon signalling during viral infection | Nature Microbiology
How cancer cells make and respond to interferon-I: Trends in Cancer
Interferon Tau - an overview | ScienceDirect Topics
Types of Interferons and Their Expression in Plant Systems | Journal of Interferon & Cytokine Research
Frontiers | All About the RNA: Interferon-Stimulated Genes That Interfere With Viral RNA Processes
Frontiers | An NFκB Activity Calculator to Delineate Signaling Crosstalk: Type I and II Interferons Enhance NFκB via Distinct Mechanisms
The role of nuclear factor κB in the interferon response. | Semantic Scholar
A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 - eClinicalMedicine
Frontiers | Evasion of interferon-mediated immune response by arteriviruses